Search bioRxiv⌕ Search

Biology subjects

Wang, P.-h.

Publications and source records attributed to Wang, P.-h..

2 recordsLinked to original sources

TENT5A anchors STING at the endoplasmic reticulum to block SEC24B-dependent trafficking and suppress cGAS-STING signaling

The cGAS-STING pathway is a central sensor of cytosolic DNA that drives type I interferon responses during infection and tumor surveillance. Activation of STING requires coordinated trafficking from the endoplasmic reticulum (ER) to the Golgi, yet how this spatial transition is regulated by ER-resident factors remains incompletely understood. Here we identify TENT5A as an ER-localized negative regulator of STING signaling. Genetic depletion of TENT5A markedly enhances cGAS-STING-dependent type I interferon production in response to cytosolic DNA and DNA virus infection. Conversely, TENT5A overexpression suppresses downstream signaling and antiviral gene expression. Mechanistically, TENT5A directly interacts with the C-terminal tail of STING and competes with the COPII adaptor SEC24B, thereby preventing STING incorporation into COPII vesicles and blocking its ER-to-Golgi trafficking. This ER retention inhibits STING oligomerization, TBK1 recruitment and IRF3 activation, ultimately attenuating type I interferon responses. In vivo, myeloid-specific deletion of TENT5A enhances systemic interferon responses, restricts herpesvirus replication, and improves host survival. Moreover, TENT5A deficiency promotes CD8 T cell effector activation within the tumor microenvironment and suppresses tumor growth in a melanoma model. Together, our findings define TENT5A as an ER checkpoint that spatially controls STING trafficking through competition with COPII machinery, revealing vesicular sorting as a regulatory layer of innate immune activation.

immunology↗

Sequential ER stress and inflammatory responses are induced by SARS-CoV-2 ORF3 through ERphagy

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have resulted in a number of severe cases of COVID-19 and deaths worldwide. However, knowledge of SARS-CoV-2 infection, diseases and therapy remains limited, underlining the urgency of fundamental studies and drug development. Studies have shown that induction of autophagy and hijacking of autophagic machinery are essential for infection and replication of SARS-CoV-2; however, the mechanism of this manipulation and function of autophagy during SARS-CoV-2 infection remain unclear. In the present study, we identified ORF3 as an inducer of autophagy and revealed that ORF3 localizes to the ER and induces FAM134B-related ERphagy through the HMGB1-Beclin1 pathway. As a consequence, ORF3 induces ER stress and inflammatory responses through ERphagy and sensitizes cells to ER stress-induced cell death, suggesting that SARS-CoV-2 ORF3 hijacks ERphagy and then harms ER homeostasis to induce inflammatory responses through excessive ER stress. These findings reveal a sequential induction of ERphagy, ER stress and acute inflammatory responses during SARS-CoV-2 infection and provide therapeutic potential for ERphagy and ER stress-related drugs for COVID-19 treatment and prevention. ImportanceSARS-CoV-2 infection and replication require autophagosome-like double-membrane vacuoles. Inhibition of autophagy suppresses viral replication, indicating the essential role of autophagy in SARS-CoV-2 infection. However, how SARS-CoV-2 hijacks autophagy and the function of autophagy in the disease progression remain unknown. Here, we reveal that SARS-CoV-2 ORF3 induces ERphagy and consequently induces ER stress to trigger acute inflammatory responses and enhance sensitivity to ER stress-induced apoptosis. Our studies uncover ERphagy-induced inflammatory responses during SARS-CoV-2 infection and provide a promising therapeutic approach for treating SARS-CoV-2 infection and inflammatory responses in COVID-19 by manipulating autophagy and ER stress.

microbiology↗